1. D.W. Kaiser, J.T. Thurston, J.R. Dudley, F.C. Sçhaefer, I. Hechenbleikner and D. Holm-Harsen, Cyanuric chloride derivatives II, J. Am. Ghem. Soc. 73:2984 (1951).
2. J.A. Hendry, F.L. Rose, A.L. Walpole, Cytotoxic agents III. Derivatives of ethyleneimines, Br. J. Pharmacol. 6:357 (1951)
3. J.A. Hendry, F.L. Rose, A.L. Walpole, Cytotoxic agents: I, methylolamides with tumour inhibitory activity, and related inactive compounds. Br. J. Pharmacol. 6:201(1951).
4. L.W. Wilson and J.G. de la Garza, Phase I study of hexamethylmelamine (NSC-13875), Cancer Chemother. Rep. 48: 49–53 (1965).
5. J. Louis, N.B. Louis, J.W. Linman, W.J. Donnelly, B.L. Isaacs and S.O. Schwartz, The clinical pharmacology of hexamethylmelamine: Phase I study, Clin. Pharm and Therapeutics 8:55 (1967).